Achieve Life Sciences, Inc. (ACHV) NASDAQ
5.03
-0.27(-5.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 216.67M |
| Enterprise Value | 210.69M |
| P/E Ratio | -5.16 |
| PEG Ratio | -0.33 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 25.15 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.57 |
| Return On Equity | -1.93 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -228,000 |
| EBITDA | -54.65M |
| Net Income | -54.65M |
| Diluted EPS | -1.25 |
Balance Sheet
| Total Cash | 29.27M |
| Total Cash/Share | 0.55 |
| Total Debt | 14.95M |
| Total Debt/Equity | 1.4 |
| Current Ratio | 2.62 |
| Book Value Per Share | 0.2 |
Price History
| 52-Week Change | 28.97 |
| 52-Week High | 6.15 |
| 52-Week Low | 2 |
| Moving Average 50 Days | 4.22 |
| Moving Average 200 Days | 4.17 |
Statistics
| Average Volume | 1.28M |
| Shares Outstanding | 102.66M |
| % Held by Institutions | 49.37 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 31, 2020 |
